Data as of Jul 25
| +4.78 / +7.30%|
The 16 analysts offering 12-month price forecasts for LifePoint Hospitals Inc have a median target of 64.50, with a high estimate of 75.00 and a low estimate of 55.00. The median estimate represents a -8.21% decrease from the last price of 70.27.
The current consensus among 22 polled investment analysts is to Hold stock in LifePoint Hospitals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.